Article in American journal of physiology. Lung cellular and molecular physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Stefan HadzicExcellence Cluster Cardio-Pulmonary Institute (CPI), Justus Liebig University Giessen, Giessen, Germany.ORCID 0000-0001-8459-2776
Simon J ClearyInstitute of Pharmaceutical Science & Centre for Lung Health, King's College London, London, United Kingdom.ORCID 0000-0001-5573-6363
Daniel Colon HidalgoDivision of Pulmonary, Allergy, and Critical Care Medicine, University of Colorado Anschutz, Aurora, Colorado, United States.
Jana GruneDepartment of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Der Charité (DHZC), Berlin, Germany.ORCID 0000-0001-6209-7416
Kadija HersiCritical Care Medicine and Pulmonary Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States.
Corrine R KlimentDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.ORCID 0000-0002-3815-9370
Elena Lopez-RodriguezInstitute of Functional Anatomy, Charité Universitätsmedizin Berlin, member of the German Center for Lung Research (DZL), Berlin, Germany.ORCID 0000-0002-1549-8150
Jamie E MeeganDepartment of Physiology and Cell Biology and Center for Lung Biology, University of South Alabama, Mobile, Alabama, United States.ORCID 0000-0002-2644-676X
Samuel G RaynerCenter for Lung Biology, University of Washington, Seattle, Washington, United States.ORCID 0000-0002-2541-4221
Kent A WillisDivision of Neonatology, Department of Pediatrics, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, United States.ORCID 0000-0001-7338-0399
Alicia N RizzoDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.ORCID 0000-0001-9289-4635
Funding
Hemodynamic Contributions to Vascular Dysfunction in Pulmonary Arterial HypertensionK08HL166696 · NHLBI · UNIVERSITY OF WASHINGTON · PI Samuel Gibson Rayner · 2023 to 2026
$793k
The impact of glycocalyx degradation on ARDS pathogenesis and outcomesK23HL173662 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Alicia N Rizzo · 2025 to 2026
$377k
Academy of Medical Sciences (The Academy of Medical Sciences)Deutsche Forschungsgemeinschaft (DFG) Project ID: 390649896Foundation for the National Institutes of Health (FNIH) K08HL166696HHS | NIH | NHLBI | Division of Intramural Research (DIR)NHLBI NIH HHS K23 HL173662Uniklinikum Giessen und Marburg (UKGM) 05/2023GI
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Opening the black box: reflections from the AJP-Lung early career editorial fellows. · full record | OpenQuestion